STAT3 and cancer: Previous reports have also shown that certain drugs can inhibit cancer metastasis by blocking EMT in malignant cells and reduce drug susceptibility by deactivating EMT-related pathways, including the AKT and STAT3 signaling pathways [115,116,117].